LFMD Q4 2024 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q4 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$64M+43.2% YoY

Gross Profit

$55M85.3% margin

Operating Income

$1M1.6% margin

Net Income

-$106,272-0.2% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+20.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$1M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$72M

Total Liabilities

$77M

Stockholders' Equity

-$5M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$45M	+43.2%
Gross Profit	$55M	$40M	+38.8%
Operating Income	$1M	-$2M	+146.9%
Net Income	-$106,272	-$4M	+97.2%